Unni C Nygaard1,2, Lan Xiao3, Kari C Nadeau1, Kinjal M Hew1, Nan Lv4, Carlos A Camargo5, Peg Strub6, Jun Ma7. 1. Sean N Parker Center for Allergy and Asthma Research, Division of Pulmonary and Critical Care Medicine and Division of Allergy, Immunology and Rheumatology, Stanford University, Stanford, CA, USA. 2. Department for Environmental Health, Norwegian Institute of Public Health, Oslo, Norway. 3. Department of Medicine, Stanford University, Palo Alto, CA, USA. 4. Institute of Health Research and Policy, University of Illinois at Chicago, Chicago, IL, USA. 5. Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 6. Department of Allergy, Asthma and Immunology, Kaiser Permanente San Francisco, San Francisco, CA, USA. 7. Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Abstract
BACKGROUND: Asthma has become one of the major public health challenges, and recent studies show promising clinical benefits of dietary interventions, such as the Dietary Approaches to Stop Hypertension (DASH) diet. OBJECTIVE: The objective of this study was to examine whether changes in diet quality are associated with changes in inflammatory markers important in asthma pathophysiology. METHODS: In this exploratory study in patients with poorly controlled asthma participating in a randomized controlled trial of a DASH intervention study, changes in concentrations of a broad panel of serum proteins (51-plex Luminex assay, Affymetrix) were determined, and their relation to diet quality (DASH score) assessed by combining data of both intervention and usual-care control groups. Second, the relation between the serum proteins, other biomarkers of inflammation and nutrition, and Asthma Control Questionnaire (ACQ) was assessed. RESULTS: During the first 3 mo, diet quality (DASH scores) were inversely associated (P < 0.05, false discovery rate P < 0.09) with serum concentrations of a large number serum proteins, reflecting not only general proinflammatory markers such as IL-1β, transforming growth factor α (TGF-α), and IL-6 (r = -0.31 to -0.39) but also a number of proteins associated with asthmatic conditions, specifically several T-helper (Th) 2 (Th2; r = -0.29 to -0.34) and Th17 (r = -0.4) associated cytokines and growth factors. Monokine induced by gamma/chemokine (C-X-C motif) ligand 9 (CXCL9) (MIG/CXCL9), a T-cell attractant induced by IFN-γ previously linked to asthma exacerbations, appeared to be the marker most consistently associated with DASH diet quality for the entire 6-mo study period (r = -0.40 and -0.30 for 0-3 and 3-6 mo, respectively, and standardized coefficient loadings -0.13 in the partial least squares analyses). Decreases in 19 serum protein concentrations were also correlated with improved asthma control during the 6-mo study period. CONCLUSIONS: Our data in adult patients with poorly controlled asthma suggest that dietary changes, like the introduction of DASH, may have beneficial effects on reducing inflammatory status. This trial was registered at http://www.clinicaltrials.gov as NCT01725945.
BACKGROUND: Asthma has become one of the major public health challenges, and recent studies show promising clinical benefits of dietary interventions, such as the Dietary Approaches to Stop Hypertension (DASH) diet. OBJECTIVE: The objective of this study was to examine whether changes in diet quality are associated with changes in inflammatory markers important in asthma pathophysiology. METHODS: In this exploratory study in patients with poorly controlled asthma participating in a randomized controlled trial of a DASH intervention study, changes in concentrations of a broad panel of serum proteins (51-plex Luminex assay, Affymetrix) were determined, and their relation to diet quality (DASH score) assessed by combining data of both intervention and usual-care control groups. Second, the relation between the serum proteins, other biomarkers of inflammation and nutrition, and Asthma Control Questionnaire (ACQ) was assessed. RESULTS: During the first 3 mo, diet quality (DASH scores) were inversely associated (P < 0.05, false discovery rate P < 0.09) with serum concentrations of a large number serum proteins, reflecting not only general proinflammatory markers such as IL-1β, transforming growth factor α (TGF-α), and IL-6 (r = -0.31 to -0.39) but also a number of proteins associated with asthmatic conditions, specifically several T-helper (Th) 2 (Th2; r = -0.29 to -0.34) and Th17 (r = -0.4) associated cytokines and growth factors. Monokine induced by gamma/chemokine (C-X-C motif) ligand 9 (CXCL9) (MIG/CXCL9), a T-cell attractant induced by IFN-γ previously linked to asthma exacerbations, appeared to be the marker most consistently associated with DASH diet quality for the entire 6-mo study period (r = -0.40 and -0.30 for 0-3 and 3-6 mo, respectively, and standardized coefficient loadings -0.13 in the partial least squares analyses). Decreases in 19 serum protein concentrations were also correlated with improved asthma control during the 6-mo study period. CONCLUSIONS: Our data in adult patients with poorly controlled asthma suggest that dietary changes, like the introduction of DASH, may have beneficial effects on reducing inflammatory status. This trial was registered at http://www.clinicaltrials.gov as NCT01725945.
Authors: Caroline Roduit; Remo Frei; Ruth Ferstl; Susanne Loeliger; Patrick Westermann; Claudio Rhyner; Elisa Schiavi; Weronika Barcik; Noelia Rodriguez-Perez; Marcin Wawrzyniak; Christophe Chassard; Christophe Lacroix; Elisabeth Schmausser-Hechfellner; Martin Depner; Erika von Mutius; Charlotte Braun-Fahrländer; Anne M Karvonen; Pirkka V Kirjavainen; Juha Pekkanen; Jean-Charles Dalphin; Josef Riedler; Cezmi Akdis; Roger Lauener; Liam O'Mahony Journal: Allergy Date: 2018-11-25 Impact factor: 13.146
Authors: A Lambiase; L Bracci-Laudiero; S Bonini; S Bonini; G Starace; M M D'Elios; M De Carli; L Aloe Journal: J Allergy Clin Immunol Date: 1997-09 Impact factor: 10.793
Authors: Michael C Peters; Kelly Wong McGrath; Gregory A Hawkins; Annette T Hastie; Bruce D Levy; Elliot Israel; Brenda R Phillips; David T Mauger; Suzy A Comhair; Serpil C Erzurum; Mats W Johansson; Nizar N Jarjour; Andrea M Coverstone; Mario Castro; Fernando Holguin; Sally E Wenzel; Prescott G Woodruff; Eugene R Bleecker; John V Fahy Journal: Lancet Respir Med Date: 2016-06-06 Impact factor: 30.700
Authors: Jun Ma; Peg Strub; Nan Lv; Lan Xiao; Carlos A Camargo; A Sonia Buist; Philip W Lavori; Sandra R Wilson; Kari C Nadeau; Lisa G Rosas Journal: Eur Respir J Date: 2015-10-22 Impact factor: 16.671